Barely Significant
← all phrases

“a definite trend”

428 sentences · 428 papers · 788 search hits before verification · confirmed specimen

Sighted at

p=0.08

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

In this study, a definite trend is evident that the incidence of malperfusion (including myocardial infarction, ischemic stroke and acute renal injury) in the high-WBCc group were higher than those in the normal-WBCc group, although there was no statistical difference ( P = 0.094; P = 0.683; P = 0.264, respectively).
On further analysis grade I tumours, lymph node-negative tumours, patients with <3 positive lymph nodes and ER/PR positive tumours showed a definite trend to have only unmethylated alleles i.e. active p16.
Poster presentations
Br J Cancer · 2000 · PMC2363545
Keywords: Acute exacerbation, chronic obstructive pulmonary disease, predictors of outcome, rural area status released display-pdf yes is-olf no is-manuscript no is-preprint no is-journal-matter no is-scanned no is-retracted no Introduction Chronic obstructive pulmonary disease (COPD) is a major cause of death and disability around the world.[ 1 ] The age-adjusted death rate of this disease is highest in low-income areas of the world including South Asia and sub-Saharan Africa.[ 2 ] Even in high-income countries, there is a definite trend in socioeconomic related outcome with those in the lower socioeconomic status faring worse.[ 3 ] The high economic burden this disease imposes on the individual, and the health care delivery system of a nation needs to be emphasized.[ 4 ] In the Indian context, there is limited data regarding prevalence of COPD.
Finally, the NDR observed in the lateral GO devices is completely different from the noise and random peaks usually observed in the I-V characteristics of devices based on GO or other oxides, as the NDR peaks in this study are repeatable and follow a definite trend, unlike peaks due to random charge trapping and emission at high density of defect sites in GO or other oxides 49 .
Adult treatment panel-II Adult treatment panel-II was based on observational epidemiological review, lipoprotein metabolism, animal studies, and early clinical trials.[ 7 , 8 ] Pooling of data from early clinical trials revealed a definite trend towards reduced total mortality in patients with CHD but no clinical trial or meta-analysis showed reduction in total mortality in the primary prevention patients.[ 14 ] ATP-II recommended a cautious use of lipid lowering agents in primary prevention of CHD since benefits from pharmacological treatment of lower risk patients would diminish by increased relative risks and cost of the therapy.
Although the data on the outcomes of liver transplant recipients with COVID-19 are inconsistent, there is a definite trend towards higher mortality risks in transplant recipients. 4 , 5 Liver transplant recipients or other immunocompromised patients were not included in the registration trials of mRNA vaccine studies for SARS-CoV-2.